Small-Molecule Protein Tyrosine Phosphatase Inhibition as a Neuroprotective Treatment after Spinal Cord Injury in Adult Rats
Open Access
- 16 July 2008
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 28 (29), 7293-7303
- https://doi.org/10.1523/jneurosci.1826-08.2008
Abstract
Spinal cord injury causes progressive secondary tissue degeneration, leaving many injured people with neurological disabilities. There are no satisfactory neuroprotective treatments. Protein tyrosine phosphatases inactivate neurotrophic factor receptors and downstream intracellular signaling molecules. Thus, we tested whether the peroxovanadium compound potassium bisperoxo(1,10-phenanthroline)oxovanadate (V) [bpV(phen)], a stable, potent and selective protein tyrosine phosphatase inhibitor, would be neuroprotective after a thoracic spinal cord contusion in adult rats. Intrathecal bpV(phen) infusions through a lumbar puncture rescued dorsal column sensory axons innervating the nucleus gracilis and white matter at the injury epicenter. At the most effective dose, essentially all of these axons and most of the white matter at the epicenter were spared (vs ∼60% with control infusions). bpV(phen) treatments started 4 h after contusion were fully effective. This treatment greatly improved and normalized sensorimotor function in a grid-walking test and provided complete axonal protection over 6 weeks. The treatment rescued sensory-evoked potentials that disappeared after dorsal column transection. bpV(phen) affected early degenerative mechanisms, because the main effects were seen at 7 d and lasted beyond the treatment period. The neuroprotection appeared to be mediated by rescue of blood vessels. bpV(phen) reduced apoptosis of cultured endothelial cells. These results show that a small molecule, used in a clinically relevant manner, reduces loss of long-projecting axons, myelin, blood vessels, and function in a model relevant to the most common type of spinal cord injury in humans. They reveal a novel mechanism of spinal cord degeneration involving protein tyrosine phosphatases that can be targeted with therapeutic drugs.Keywords
This publication has 54 references indexed in Scilit:
- Spinal Cord Contusion Based on Precise Vertebral Stabilization and Tissue Displacement Measured by Combined Assessment to Discriminate Small Functional DifferencesJournal of Neurotrauma, 2008
- Vanadate-induced cell death is dissociated from H2O2 generationCell Biology and Toxicology, 2007
- Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6‐OHDA treated adult ratsEuropean Journal of Neuroscience, 2007
- Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cordExperimental Neurology, 2006
- An Adult Rat Spinal Cord Contusion Model of Sensory Axon Degeneration: The Estrus Cycle or a Preconditioning Lesion Do Not Affect OutcomeJournal of Neurotrauma, 2005
- A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injuryExperimental Neurology, 2004
- Cyclosporin A Treatment Following Spinal Cord Injury to the Rat: Behavioral Effects and Stereological Assessment of Tissue SparingJournal of Neurotrauma, 2001
- Early Signaling Events Triggered by Peroxovanadium [bpV(phen)] Are Insulin Receptor Kinase (IRK)-Dependent: Specificity of Inhibition of IRK-Associated Protein Tyrosine Phosphatase(s) by bpV(phen)Molecular Endocrinology, 1997
- Peroxovanadium compounds: Biolgoical actions and mechanism of insulin-mimesisMolecular and Cellular Biochemistry, 1995
- Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signalingMolecular and Cellular Biochemistry, 1995